MBIO - ムスタング・バイオ (Mustang Bio Inc.) ムスタング・バイオ

 MBIOのチャート


 MBIOの企業情報

symbol MBIO
会社名 Mustang Bio Inc (ムスタング・バイオ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 Mustang Bio Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cancer immunotherapy products designed to utilize the power of the patient’s own immune system to eliminate cancer cells. It seeks to acquire rights to technologies by licensing or otherwise acquiring an ownership interest in the technologies funding their research and development and eventually either out-licensing or bringing the technologies to market. The Company is developing its proprietary Chimeric Antigen Receptor (CAR) engineered T cells (CAR -T) technology which uses the patient’s own T cells to engage and destroy specific tumors. The Company through its agreement with City of Hope National Medical Center is using three novel CAR T therapies in the development of cancer treatments including human epidermal growth factor receptor 2 CAR T technology CS1-specific CAR T technology and prostate stem cell antigen CAR T technology.   ムスタング・バイオは米国のバイオ医薬品企業。臨床段階で、免疫療法によるがん治療法の開発・商業化に従事する。患者自身の免疫システムの効果を利用し、がん細胞を排除する治療法に焦点を当てる。同社は研究開発のためライセンス供与などでテクノロジ―の所有権を取得し、最終的にはテクノロジ―を市場に投入する方向。本社所在地はニューヨーク。   Mustang Bio, Inc. is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of a broad range of proprietary chimeric antigen receptor engineered T cell (CAR T) immunotherapies and gene therapies. It develops CAR T and CRISPR/Cas9-enhanced CAR T therapies across multiple cancers, as well as lentiviral gene therapy for XSCID. The firm's products include MB-101 IL13Ra2-specific CAR, MB-102 CD123 CAR, MB-103 HER2 CAR, MB-104 CS1 CAR, MB-105 PSCA CAR, MB-106 CD20 CAR, MB-107 XSCID Gene Therapy and Oncolytic Virus (C134). The company was founded on March 13, 2015 and is headquartered in Worcester, MA.
本社所在地 2 Gansevoort Street 9th Floor New York NY 10014 USA
代表者氏名
代表者役職名
電話番号 +1 781-652-4507
設立年月日 42064
市場名 NASDAQ National Market System
ipoyear ―年
従業員数
url www.mustangbio.com
nasdaq_url https://www.nasdaq.com/symbol/mbio
adr_tso
EBITDA EBITDA(百万ドル) -34.35600
終値(lastsale) 5.25
時価総額(marketcap) 143132608.5
時価総額 時価総額(百万ドル) 126.22930
売上高 売上高(百万ドル) 0.05000
企業価値(EV) 企業価値(EV)(百万ドル) 79.48530
当期純利益 当期純利益(百万ドル) -33.91500
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Mustang Bio Inc revenues increased from $0K to $50K. Net loss increased 30% to $11.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and development increase from $3.2M to $7.8M (expense) General and administrative increase of 3% to $3.8M (expense).

 MBIOのテクニカル分析


 MBIOのニュース

   Is Mustang (MBIO) Stock a Solid Choice Right Now?  2020/05/21 12:32:00 Zacks Investment Research
Mustang (MBIO) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
   Mustang Bio beats by $0.03  2019/05/10 11:38:26 Seeking Alpha
   Mustang Bio off 12% after pricing stock offering  2019/04/30 14:14:40 Seeking Alpha
   Mustang Bio readies stock offering; shares down 11% after hours  2019/04/29 20:04:36 Seeking Alpha
   Mustang Bio Looks To Change Scope Of Treatment For Bubble Boy Disease  2019/04/25 06:32:54 Seeking Alpha
   Mustang Bio beats by $0.03  2019/05/10 11:38:26 Seeking Alpha
   Mustang Bio off 12% after pricing stock offering  2019/04/30 14:14:40 Seeking Alpha
   Mustang Bio readies stock offering; shares down 11% after hours  2019/04/29 20:04:36 Seeking Alpha
   Mustang Bio Looks To Change Scope Of Treatment For Bubble Boy Disease  2019/04/25 06:32:54 Seeking Alpha
   ISRG and CTST among premarket losers  2019/04/22 13:08:53 Seeking Alpha
   Mustang Bio beats by $0.03  2019/05/10 11:38:26 Seeking Alpha
   Mustang Bio off 12% after pricing stock offering  2019/04/30 14:14:40 Seeking Alpha
   Mustang Bio readies stock offering; shares down 11% after hours  2019/04/29 20:04:36 Seeking Alpha
   Mustang Bio Looks To Change Scope Of Treatment For Bubble Boy Disease  2019/04/25 06:32:54 Seeking Alpha
   ISRG and CTST among premarket losers  2019/04/22 13:08:53 Seeking Alpha

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 ムスタング・バイオ MBIO Mustang Bio Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)